Phase II Trial of Intrahepatic Artery Chemotherapy With Nexavar [sorafenib] in Hepatocellular Carcinoma Patients.
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Sorafenib (Primary) ; Carboplatin; Cisplatin
- Indications Liver cancer
- Focus Adverse reactions
- 04 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Apr 2009 New trial record